Comparative Effect of Fluoxetine and Imipramine on Social Defeat Stress Model of Depression in Mice
Article Sidebar
Views | PDF/EPUB Downloads:
165
/ 88
/ 5
Main Article Content
Abstract
Fluoxetine and imipramine are antidepressant drugs used in the management of depression. This study aimed to evaluate the comparative effect of fluoxetine and imipramine on social defeat stress (SDS)-induced depression in mice. Twenty-eight mice were divided into four groups as follows: 1 - Control (distilled water), 2 - untreated SDS, 3 - SDS + fluoxetine (10 mg/kg), and 4 - SDS + imipramine (10 mg/kg). Fluoxetine and imipramine were administered orally once daily for 14 days. At the end of treatment period, behavioural tests, including tail suspension test (TST), forced swim test (FST), sucrose splash test (SST), and social interaction test (SIT) were conducted, after which the animals were sacrificed, and blood samples were collected for biochemical analysis. Mice brain were harvested for immune-histochemical and histological analysis. Results showed that fluoxetine decreased immobility time significantly (p < 0.05) in the TST and FST compared to imipramine, while in SST, imipramine increased sucrose preference significantly (p < 0.05) compared to fluoxetine. Both drugs boosted antioxidant levels in SDS mice, but fluoxetine had a better effect on catalase than imipramine. Both drugs increased levels of corticosterone and norepinephrine to similar extent in the prefrontal cortex (PFC). Fluoxetine significantly (p < 0.05) increased serotonin levels compared to imipramine. Both drugs significantly increased neuronal density to similar extent in the medial PFC, hippocampus, and adrenal gland of SDS mice compared to the untreated SDS mice. This study has revealed that fluoxetine had a better antidepressant effect than imipramine as shown in the behavioural models.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Hazell P. Updates in treatment of depression in children and adolescents. Curr Opin Psychiatry. 2021; 34(6):593-599.
Vasileva M, Graf RK, Reinelt T, Petermann U, Petermann F. Research review: A meta‐analysis of the international prevalence and comorbidity of mental disorders in children between 1 and 7 years. J Child Psychol Psychiatry. 2021; 62(4):372-381.
Tyagi R, Chen X, Dhar A, Yang B, Zhou W, Reheman A, Cao G. Chronic social defeat stress-induced depression reduces BCG efficacy by promoting regulatory T-cell levels in mice. Anim Dis. 2023; 3(1):40.
Jörns-Presentati A, Napp AK, Dessauvagie AS, Stein DJ, Jonker D, Breet E, Charles W, Swart RL, Lahti M, Suliman S, Jansen R. The prevalence of mental health problems in sub-Saharan adolescents: A systematic review. Plos One. 2021; 16(5):0251689.
Beck A, LeBlanc JC, Morissette K, Hamel C, Skidmore B, Colquhoun H, Lang E, Moore A, Riva JJ, Thombs BD, Patten S, Bragg H, Colman I, Goldfield GS, Nicholls SG, Pajer K, Potter BK, Meeder R, Vasa P, Hutton B, Shea BJ, Graham E, Little J, Moher D, Stevens A. Screening for depression in children and adolescents: a protocol for a systematic review update. Syst Rev. 2021; 10(1):24.
Xu M, Liu S, Chen J, Yin A, He Q, Jiang Z, Liu J. Relationships among life events, emotional symptoms and non-suicidal self-injury behaviors in adolescents with depression. Psychiatry J. 2020; 33(6):420-423.
Waasdorp TE, Mehari KR, Milam AJ, Bradshaw CP. Health-related risks for involvement in bullying among middle and high school youth. J child fam stud. 2019; 28:2606-2617.
Armitage R. Bullying in children: impact on child health. BMJ paediatr open. 2021; 5(1):e000939.
Hartley SM. Assessment of Behaviors and Beliefs Exhibited by African American Practicing Physicians Toward Clinical Trial Research (Doctoral dissertation, Capella University). 2021; 28321065: 1–24 pp.
Jadambaa A, Thomas HJ, Scott JG, Graves N, Brain D, Pacella R. Prevalence of traditional bullying and cyberbullying among children and adolescents in Australia: A systematic review and meta-analysis. Aust N Z J Psychiatry. 2019; 53(9):878-888.
Ngo AT, Nguyen LH, Dang AK, Hoang MT, Nguyen THT, Vu GT, Ho CS. Bullying experience in urban adolescents: Prevalence and correlations with health-related quality of life and psychological issues. PloS One. 2021; 16(6):e0252459.
Demin KA, Sysoev M, Chernysh MV, Savva AK, Koshiba M, Wappler-Guzzetta EA, Song C, De Abreu MS, Leonard B, Parker MO, Harvey BH. Animal models of major depressive disorder and the implications for drug discovery and development. Expert Opin Drug Discov. 2019; 14(4):365-378.
Browne CA, Falcon E, Robinson SA, Berton O, Lucki I. Reversal of stress-induced social interaction deficits by buprenorphine. Int J Neuropsychopharmacol. 2018; 21(2):164-174.
Trivedi MH, Rush AJ, Wisniewski SR. Treatment and outcomes of depression. Am J Psychiatry. 2021; 178(10):899–915.
Dold M, Kasper S, Zajkowska Z. Efficacy and tolerability of imipramine in the treatment of major depression: a meta-analysis of randomized controlled trials. CNS Drugs. 2016; 30(3):243–258.
Saikarthik J, Gunapriya R, Saraswathi I, Vijayakumar J, Vijayaraghavan R. Effect of fluoxetine on hippocampus of Wistar Albino Rats in cold restraint stress model. J Clin Diagn Res. 2017; 11(6):AF01-AF06
Malick JB. The pharmacology of isolation-induced aggressive behavior in mice. Curr Dev Psychopharmacol. 1979; 5:1-27.
Blanchard RJ and Blanchard DC. Aggressive behavior in the rat. Behav Biol. 1977; 21(2):197-224.
Cryan JF, Mombereau C, Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev. 2005; 29(4-5):571-625.
Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacol. 1985; 85(3):367-370.
Burstein O and Doron R. The unpredictable chronic mild stress protocol for inducing anhedonia in mice. J Vis Exp. 2018; (140):58184.
Aluko OM, Umukoro S, Annafi OS, Adewole FA, Omorogbe O. Effects of methyl jasmonate on acute stress responses in mice subjected to forced swim and anoxic tests. Sci Pharm. 2015; 83(4):635-644.
File SE and Deakin JFW. Chemical lesions of both dorsal and median raphe nuclei and changes in social and aggressive behaviour in rats. Pharmacol Biochem Behav. 1980; 12(6):855-859.
Ben-Azu B, Adebayo OG, Wopara I, Aduema W, Onyeleonu I, Umoren EB, Kolawole TA, Ebo OT, Akpotu AE, Ajibo DN, Onuoha OG. Lead acetate induces hippocampal pyramidal neuron degeneration in mice via up-regulation of executioner caspase-3, oxido-inflammatory stress expression and decreased BDNF and cholinergic activity: Reversal effects of Gingko biloba supplement. J Trace Elem Med Biol. 2022; 71:126919.
Xie J, Cheng D, Li P, Xu Z, Zhu X, Zhang Y, Yao S. Au/metal–organic framework nanocapsules for electrochemical determination of glutathione. ACS Appl Nano Mater. 2021; 4(5):4853-4862.
Shaywitz AJ and Greenberg ME. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem. 1999; 68:821-861.
Osmond RIW, Sheehan A, Borowicz R, Barnett E, Harvey G, Turner C, Brown A, Crouch MF, Dyer AR. GPCR Screening via ERK1/2: A Novel Platform for screening G protein-coupled receptors. J Biomol. 2005; 10(7):730-737.
Halverson NG. “Frozen”: Tonic Immobility and Posttraumatic Outcomes Among Survivors of Sexual Assault. University of Montana. 2023.
Sbrini G, Brivio P, Bosch K, Homberg JR, Calabrese F. Enrichment environment positively influences depression-and anxiety-like behavior in serotonin transporter knockout rats through the modulation of neuroplasticity, spine, and GABAergic markers. Genes. 2020; 11(11):1248.
Bullich S, Delcourte S, Haddjeri N, Guiard BP. Learned immobility produces enduring impairment of the HPA axis reactivity in mice without replicating the broad spectrum of depressive-like phenotype. Int J Mol Sci. 2021; 22(2):937.
Dos Santos BM, Pereira GC, Piton E, Fialho MFP, Becker G, da Silva Carlotto M, Camargo LFM, Ramanzini LG, Oliveira SM, Trevisan G, Zanchet EM. Lower antidepressant response to fluoxetine is associated with anxiety-like behavior, hippocampal oxidative imbalance, and increase on peripheral IL-17 and IFN-γ levels. Behav Brain Res. 2022; 425:113815.
Rincón-Cortés M and Grace AA.. Antidepressant effects of ketamine on depression-related phenotypes and dopamine dysfunction in rodent models of stress. Behav Brain Res. 2022; 379:112367.
Riegel B, Dunbar SB, Fitzsimons D, Freedland KE, Lee CS, Middleton S, Stromberg A, Vellone E, Webber DE, Jaarsma T. Self-care research: where are we now? Where are we going? Int J Nurs Stud. 2021; 116:103402.
McLaughlin L. A Review of Serotonin’s Role in Depression and Modern Perspectives. 2022.
Ugwu PI, Ben-Azu B, Ugwu SU, Uruaka CI, Nworgu CC, Okorie PO, Okafor KO, Anachuna KK, Elendu MU, Ugwu AO, Anyaehie UB, Nwankwo AA, Osim EE. Preventive putative mechanisms involved in the psychopathologies of mice passively coping with psychosocial defeat stress by quercetin. Brain Res Bull. 2022; 183:127-141.
Barbosa ML, Melo de Meneses AP, Sousa de Aguiar RP, Marcelo de Castro e Sousa J, Cavalcante AACM, Maluf SW. Oxidative stress, antioxidant defense and depressive disorders: a systematic review of biochemical and molecular markers. Neurol Psychiatry Brain Res. 2020; 36(1):65-72.
Cecerska-Heryć E, Polikowska A, Serwin N, Roszak M, Grygorcewicz B, Heryć R, Michalczyk A, Dołęgowska B. Importance of oxidative stress in the pathogenesis, diagnosis, and monitoring of patients with neuropsychiatric disorders, a review. Neurochem. Int. 2022; 153:105269.
Nandam LS, Brazel M, Zhou M, Jhaveri DJ. Cortisol and major depressive disorder—translating findings from humans to animal models and back. Front Psychiatry. 2020; 10:974.
Coccurello R. Anhedonia in depression symptomatology: Appetite dysregulation and defective brain reward processing. Behav Brain Res. 2019; 372:112041.
Asensi-Cantó A, López-Abellán MD, Castillo-Guardiola V, Hurtado AM, Martínez-Penella M, Luengo-Gil G, Conesa-Zamora P. Antitumoral effects of tricyclic antidepressants: beyond neuropathic pain treatment. Cancers. 2022; 14(13):3248.
Khushboo Siddiqi NJ, de Lourdes Pereira M, Sharma B. Neuroanatomical, biochemical, and functional modifications in brain induced by treatment with antidepressants. Mol Neurobiol. 2022; 59(6):3564-3584.
Williams R and Cleare A. Drug and Physical Treatments of Depression. In: Kingdon D, Rowlands P, Stein G, eds. Seminars in General Adult Psychiatry. College Seminars Series. Cambridge University Press; 2024. 108-146 p.
Yan Z and Rein B. Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications. Mol Psychiatry. 2022; 27(1):445-465.
Dandi E, Spandou E, Tata DA. Investigating the role of environmental enrichment initiated in adolescence against the detrimental effects of chronic unpredictable stress in adulthood: Sex-specific differences in behavioral and neuroendocrinological findings. Behav Processes. 2022; 200:104707.
Machado-Santos AR, Loureiro-Campos E, Patrício P, Araújo B, Alves ND, Mateus-Pinheiro A, Correia JS, Morais M, Bessa JM, Sousa N, Rodrigues AJ. Beyond new neurons in the adult hippocampus: imipramine acts as a pro-astrogliogenic factor and rescues cognitive impairments induced by stress exposure. Cells. 2022; 11(3):390.
Scotton WJ, Hill LJ, William AC, Barnes NM. Serotonin syndrome: pathophysiology, clinical features, management, and potential future directions. Int J Tryptophan Res. 2019; 12:1178646919873925.
Kummer KK, Mitrić M, Kalpachidou T, Kress M. The medial prefrontal cortex as a central hub for mental comorbidities associated with chronic pain. Int J Mol Sci. 2022; 21(10):3440.
Köhler CA, Freitas TH, Stubbs B, Maes M, Solmi M, Veronese N, de Andrade NQ, Morris G, Fernandes BS, Brunoni AR, Herrmann N. Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis. Mol Neurobiol. 2018; 55(5):4195-4206.
Chakrapani S, Eskander N, De Los Santos LA, Omisore BA, Mostafa JA. Neuroplasticity and the biological role of brain derived neurotrophic factor in the pathophysiology and management of depression. Cureus. 2020; 12(11):e11396.
Li W, Ali T, He K, Liu Z, Shah FA, Ren Q, Liu Y, Jiang A, Li S. Ibrutinib alleviates LPS-induced neuroinflammation and synaptic defects in a mouse model of depression. Brain Behav Immun. 2021; 92:10-24.
Rišňovská D. The effect of agonist of the metabotropic glutamate receptors LY 379268 in an animal model of psychosis. Charles University Digital Repository. 2020. Available from: https://dspace.cuni.cz/handle/20.500.11956/122223.
Sze WC. BMP3b expression and role in zonation and tumourigenesis in the adrenal cortex (Doctoral dissertation, Queen Mary University of London). 2020.
Machado-Santos AR, Loureiro-Campos E, Patrício P, Araújo B, Alves ND, Mateus-Pinheiro A, Correia JS, Morais M, Bessa JM, Sousa N, Rodrigues AJ. Beyond new neurons in the adult hippocampus: imipramine acts as a pro-astrogliogenic factor and rescues cognitive impairments induced by stress exposure. Cells. 2022; 11(3):390.
Misrani, A, Tabassum S, Wang M, Chen J, Yang L, Long C. Citalopram prevents sleep-deprivation-induced reduction in CaMKII-CREB-BDNF signaling in mouse prefrontal cortex. Brain Res Bull. 2020; 155:11-18.
Tarai S, Mukherjee R, Gupta S, Rizvanov AA, Palotás A, Chandrasekhar Pammi VS, Bit A. Influence of pharmacological and epigenetic factors to suppress neurotrophic factors and enhance neural plasticity in stress and mood disorders. Cogn. Neurodyn. 2019; 13(3):219-237.
Wang G, An T, Lei C, Zhu X, Yang L, Zhang L, Zhang R. Antidepressant-like effect of ginsenoside Rb1 on potentiating synaptic plasticity via the miR-134–mediated BDNF signaling pathway in a mouse model of chronic stress-induced depression. J Ginseng Res. 2022; 46(3):376-386.